Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21252171 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)
Conditions: Diabetes Mellitus;   Coronary Artery Disease
Interventions: Drug: prasugrel;   Drug: Clopidogrel

Indicates status has not been verified in more than two years